Vor Biopharma Files 8-K with Corporate Updates
Ticker: VOR · Form: 8-K · Filed: May 23, 2025 · CIK: 1817229
| Field | Detail |
|---|---|
| Company | Vor Biopharma Inc. (VOR) |
| Form Type | 8-K |
| Filed Date | May 23, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, filing, financial-reporting
TL;DR
Vor Biopharma filed an 8-K on May 23rd detailing corporate changes and financial updates.
AI Summary
Vor Biopharma Inc. filed an 8-K on May 23, 2025, reporting events as of May 22, 2025. The filing indicates amendments to articles of incorporation or bylaws, submission of matters to a vote of security holders, and financial statements and exhibits. The company is incorporated in Delaware and its principal executive offices are located in Cambridge, Massachusetts.
Why It Matters
This 8-K filing signals important corporate governance and financial reporting activities for Vor Biopharma Inc., which could impact investor understanding of the company's structure and recent events.
Risk Assessment
Risk Level: low — This filing is a routine corporate disclosure and does not appear to contain significant negative news or financial distress.
Key Players & Entities
- Vor Biopharma Inc. (company) — Registrant
- May 22, 2025 (date) — Earliest event reported
- May 23, 2025 (date) — Date of report
- Delaware (jurisdiction) — State of Incorporation
- Cambridge, Massachusetts (location) — Principal Executive Offices
FAQ
What specific amendments were made to Vor Biopharma's articles of incorporation or bylaws?
The filing indicates that amendments were made, but the specific details of these amendments are not provided in the summary information.
What matters were submitted to a vote of Vor Biopharma's security holders?
The filing states that matters were submitted to a vote, but the nature of these matters is not detailed in the provided text.
What financial statements and exhibits are included in this 8-K filing?
The filing mentions the submission of financial statements and exhibits, but their specific content is not described in the provided summary.
When is Vor Biopharma's fiscal year end?
Vor Biopharma's fiscal year ends on December 31st.
What is Vor Biopharma's business address?
Vor Biopharma's principal executive offices are located at 100 Cambridgepark Drive, Suite 101, Cambridge, Massachusetts, 02140.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 23, 2025 regarding Vor Biopharma Inc. (VOR).